A phase 1/2 trial of a novel viral vector gene therapy in adults with type 1 diabetes is scheduled to begin this year.
The gene therapy regimen seems to be working wonders, including restoring nearly all hearing to a seven-year-old patient ...
Scientists have a new trick to tackle TDP-43: antibodies delivered via adeno-associated virus. In the September 3 Molecular Therapy, scientists led by Damien Nevoltris at AC Immune, Lausanne, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results